Richard Ogden
RORR Inc., USA
Biography
Richard Ogden received his training in organic chemistry at Cambridge and, following postdoctoral research at UC San Diego was a founding scientist at Agouron Pharmaceuticals where he worked on discovery and development of new therapies for cancer and HIV/AIDS, notably Nelfinavir, a HIV protease inhibitor. Following acquisition by Pfizer, he led their global medical education effort in HIV and represented their research at several international venues including the WHO and the Presidential Advisory Council on HIV AIDS in the USA. He is a co-founder, with Dr Regina Rooney of RORR Inc, a scientific and medical consultancy. Clients have included small companies conducting research and development in infectious disease and the International AIDS Society.
Abstract
Abstract : HIV/AIDS: A Review of Current Treatment, Prevention and Cure Research